ArticleInternational journal of trichology2012
Madarosis: a marker of many maladies.
Article in International journal of trichology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Epidemiology of eyelid disorders in an elderly population: Tehran Geriatric Eye Study.BMC ophthalmology · 2026Article
- Long Lashes, Mixed Signals: Investigating the Effect of Eyelash Length on Perceived Health, Attractiveness, and Sexual Receptivity.Archives of sexual behavior · 2025Article
- Unilateral Madarosis Revealing Blepharitis Caused by Microsporum audouinii: A Case Report.Cureus · 2025Article
- Effects of Thioglycolate Compounds in an Emerging Technique in the World of Cosmetics-Brow Lamination.Journal of cosmetic dermatology · 2025Review
- Article
- Eyelash length attractiveness across ethnicities.Scientific reports · 2023Article
- Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination".JAAD case reports · 2022Article
- From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics.Frontiers in endocrinology · 2022Review
- Unusual case of bilateral ciliary madarosis: trichotillomania.BMJ case reports · 2021Article
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.Drug design, development and therapy · 2018Review
- Ophthalmic clues to the endocrine disorders.Journal of endocrinological investigation · 2017Review
- Irregularly luscious lashes: difficult to say but a sinister sign to miss.BMJ case reports · 2016Article
- Eyelash transplantation using leg hair by follicular unit extraction.Plastic and reconstructive surgery. Global open · 2015Article
- Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder.Journal of clinical psychopharmacologyArticle
- The eyelash follicle features and anomalies: A review.Journal of optometryReview
- Leonine Facies in Dermatology.Indian dermatology online journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Madarosis is a terminology that refers to loss of eyebrows or eyelashes. This clinical sign occurs in various diseases ranging from local dermatological disorders to complex systemic diseases. Madarosis can be scarring or non-scarring depending upon the etiology. Appropriate diagnosis is essential for management. Follicular unit transplantation has been found to be a useful method of treating scarring madarosis and the procedure relevant to eyebrow and eyelash reconstruction has been discussed. A useful clinical approach to madarosis has also been included for bedside diagnosis. The literature search was conducted with Pubmed, Medline, and Google scholar using the keywords madarosis, eyebrow loss, and eyelash loss for articles from 1960 to September 2011. Relevant material was also searched in textbooks and used wherever appropriate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.